Cargando…
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials
Stem cell-based therapies (SCT) to treat neurodegenerative disorders have promise but clinical trials have only recently begun, and results are not expected for several years. While most SCTs largely lead to a symptomatic therapeutic effect by replacing lost cell types, there may also be disease-mod...
Autores principales: | Marsili, Luca, Sharma, Jennifer, Outeiro, Tiago Fleming, Colosimo, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953050/ https://www.ncbi.nlm.nih.gov/pubmed/36831041 http://dx.doi.org/10.3390/biomedicines11020505 |
Ejemplares similares
-
Movement Disorders in Oncology: From Clinical Features to Biomarkers
por: Marsili, Luca, et al.
Publicado: (2021) -
Diagnostic Criteria for Parkinson’s Disease: From James Parkinson to the Concept of Prodromal Disease
por: Marsili, Luca, et al.
Publicado: (2018) -
Deep Brain Stimulation for Movement Disorders – A History of Success and Challenges to Conquer
por: Wojtecki, Lars, et al.
Publicado: (2012) -
Zebrafish as an Animal Model for Drug Discovery in Parkinson’s Disease and Other Movement Disorders: A Systematic Review
por: Vaz, Rita L., et al.
Publicado: (2018) -
The courage to change science
por: Outeiro, Tiago Fleming
Publicado: (2020)